Executive Summary: A Call to Action for Canadian Healthcare In a pivotal submission for the upcoming federal...
The landscape of plastic and reconstructive surgery is undergoing a profound transformation, propelled not just by surgical...
In a significant move to advance precision oncology on a global scale, cell-free DNA (cfDNA) specialist Natera...
The landscape of oncology is undergoing a fundamental transformation. At the 2026 American Society of Clinical Oncology...
Navigating the Storm: A Parent’s Guide to Open Communication with Children During a Cancer Diagnosis
Navigating the Storm: A Parent’s Guide to Open Communication with Children During a Cancer Diagnosis
By Kelsey Mora, CCLS, LCPC, Chief Clinical Officer at Pickles Group The diagnosis of cancer is a...
For decades, the human genome was a biological frontier—a vast, encrypted map that held the secrets to...
In the rapidly evolving landscape of human genetics, researchers have long grappled with a fundamental dichotomy: the...
By Katie Mooneyham and Candace Day, National Breast Cancer Foundation In the modern marketplace, Corporate Social Responsibility...
In a landmark achievement for reproductive medicine and genetic science, researchers at Newcastle University and The Newcastle...
A pivotal Phase III trial combining Gilead Sciences’ Trodelvy (sacituzumab govitecan) with Merck & Co.’s Keytruda (pembrolizumab)...
